Clinical Trial Update: TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tumor treating fields in combination with temozolomide and tislelizumab for newly diagnosed glioblastoma. The current study status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Tislelizumab (tislelizumab)
• Tumor Treating Fields (tumor treating fields)

Snippet

Sponsor: Jiangsu Healthy Life Innovation Medical Technology Co., Ltd | Conditions: Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN